SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'B07'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GHM_A_CEDA1_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	8 / 12	ALA A 48 SER A 49 LYS A 52 TYR A 147 SER A 298 ASN A 300 LYS A 410 GLY A 412	B07 A 500 (-3.8A) B07 A 500 (-1.4A) B07 A 500 (-3.4A) B07 A 500 (-4.1A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 (-1.6A) B07 A 500 (-3.2A)	1.00A	1ghmA-3zvtA: 7.1	1ghmA-3zvtA: 20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HK3_A_T44A3003_1 (SERUM ALBUMIN)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	3 / 4	LYS A 52 ALA A 56 MET A 295	B07 A 500 (-3.4A) None None	0.98A	1hk3A-3zvtA: undetectable	1hk3A-3zvtA: 23.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_A_CFXA1300_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	8 / 12	ALA A 48 SER A 49 LYS A 52 SER A 298 ASN A 300 THR A 393 LYS A 410 GLY A 412	B07 A 500 (-3.8A) B07 A 500 (-1.4A) B07 A 500 (-3.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 ( 4.8A) B07 A 500 (-1.6A) B07 A 500 (-3.2A)	0.65A	1i2wA-3zvtA: 20.3	1i2wA-3zvtA: 21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_B_CFXB2300_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	7 / 12	ALA A 48 SER A 49 LYS A 52 SER A 298 ASN A 300 THR A 393 GLY A 412	B07 A 500 (-3.8A) B07 A 500 (-1.4A) B07 A 500 (-3.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 ( 4.8A) B07 A 500 (-3.2A)	0.67A	1i2wB-3zvtA: 20.5	1i2wB-3zvtA: 21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_A_CFXA1001_1 (BETA-LACTAMASE CTX-M-9)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	7 / 12	SER A 49 LYS A 52 SER A 298 ASN A 300 THR A 393 LYS A 410 GLY A 412	B07 A 500 (-1.4A) B07 A 500 (-3.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 ( 4.8A) B07 A 500 (-1.6A) B07 A 500 (-3.2A)	0.62A	1ymxA-3zvtA: 20.8	1ymxA-3zvtA: 23.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_B_CFXB1002_1 (BETA-LACTAMASE CTX-M-9)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	6 / 12	SER A 49 LYS A 52 SER A 298 ASN A 300 LYS A 410 GLY A 412	B07 A 500 (-1.4A) B07 A 500 (-3.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 (-1.6A) B07 A 500 (-3.2A)	0.58A	1ymxB-3zvtA: 21.0	1ymxB-3zvtA: 23.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_A_CE3A301_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	6 / 12	LYS A 52 SER A 298 ASN A 300 THR A 393 LYS A 410 GLY A 412	B07 A 500 (-3.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 ( 4.8A) B07 A 500 (-1.6A) B07 A 500 (-3.2A)	0.41A	3hlwA-3zvtA: 20.9	3hlwA-3zvtA: 22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_B_CE3B302_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	6 / 12	SER A 298 ASN A 300 THR A 393 LYS A 410 THR A 411 GLY A 412	B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 ( 4.8A) B07 A 500 (-1.6A) B07 A 500 (-4.8A) B07 A 500 (-3.2A)	0.33A	3hlwB-3zvtA: 21.1	3hlwB-3zvtA: 22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_A_PNNA300_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	5 / 12	LYS A 52 ASN A 300 LYS A 410 THR A 411 GLY A 412	B07 A 500 (-3.4A) B07 A 500 ( 4.2A) B07 A 500 (-1.6A) B07 A 500 (-4.8A) B07 A 500 (-3.2A)	0.34A	3huoA-3zvtA: 20.9	3huoA-3zvtA: 22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KP2_A_PNNA5001_0 (TRANSCRIPTIONAL REGULATOR TCAR)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	4 / 8	LEU A 446 GLN A 449 SER A 418 ASN A 300	None None None B07 A 500 ( 4.2A)	1.13A	3kp2A-3zvtA: undetectable 3kp2B-3zvtA: undetectable	3kp2A-3zvtA: 16.15 3kp2B-3zvtA: 16.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MZE_A_CFXA364_1 (D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	6 / 12	ALA A 48 LYS A 52 ASN A 300 LEU A 349 THR A 411 GLY A 412	B07 A 500 (-3.8A) B07 A 500 (-3.4A) B07 A 500 ( 4.2A) B07 A 500 ( 4.9A) B07 A 500 (-4.8A) B07 A 500 (-3.2A)	0.62A	3mzeA-3zvtA: 19.4	3mzeA-3zvtA: 24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MZE_A_CFXA364_1 (D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	6 / 12	ALA A 48 SER A 49 LYS A 52 ASN A 300 THR A 411 GLY A 412	B07 A 500 (-3.8A) B07 A 500 (-1.4A) B07 A 500 (-3.4A) B07 A 500 ( 4.2A) B07 A 500 (-4.8A) B07 A 500 (-3.2A)	0.71A	3mzeA-3zvtA: 19.4	3mzeA-3zvtA: 24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3P5N_A_RBFA190_1 (RIBOFLAVIN UPTAKE PROTEIN)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	5 / 12	ASP A 345 GLY A 348 ALA A 48 ALA A 419 ASN A 438	None B07 A 500 (-4.7A) B07 A 500 (-3.8A) None None	1.10A	3p5nA-3zvtA: undetectable	3p5nA-3zvtA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3P5N_B_RBFB190_1 (RIBOFLAVIN UPTAKE PROTEIN)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	5 / 12	ASP A 345 GLY A 348 ALA A 48 ALA A 419 ASN A 438	None B07 A 500 (-4.7A) B07 A 500 (-3.8A) None None	1.10A	3p5nB-3zvtA: undetectable	3p5nB-3zvtA: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_A_WPPA300_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	5 / 12	LYS A 52 SER A 298 ASN A 300 LYS A 410 GLY A 412	B07 A 500 (-3.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 (-1.6A) B07 A 500 (-3.2A)	0.38A	3q07A-3zvtA: 20.7	3q07A-3zvtA: 22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_B_WPPB400_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	5 / 12	LYS A 52 SER A 298 ASN A 300 LYS A 410 GLY A 412	B07 A 500 (-3.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 (-1.6A) B07 A 500 (-3.2A)	0.38A	3q07B-3zvtA: 20.9	3q07B-3zvtA: 22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_A_CEDA1_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	7 / 12	ALA A 48 SER A 49 SER A 298 ASN A 300 LYS A 410 THR A 411 GLY A 412	B07 A 500 (-3.8A) B07 A 500 (-1.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 (-1.6A) B07 A 500 (-4.8A) B07 A 500 (-3.2A)	0.53A	3sh8A-3zvtA: 20.4	3sh8A-3zvtA: 22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_B_CEDB1_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	7 / 12	ALA A 48 SER A 49 LYS A 52 SER A 298 ASN A 300 LYS A 410 GLY A 412	B07 A 500 (-3.8A) B07 A 500 (-1.4A) B07 A 500 (-3.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 (-1.6A) B07 A 500 (-3.2A)	0.60A	3sh8B-3zvtA: 20.3	3sh8B-3zvtA: 22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	8 / 12	LYS A 52 SER A 298 ASN A 300 THR A 393 LYS A 410 THR A 411 GLY A 412 THR A 413	B07 A 500 (-3.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 ( 4.8A) B07 A 500 (-1.6A) B07 A 500 (-4.8A) B07 A 500 (-3.2A) None	0.76A	4euzA-3zvtA: 20.0	4euzA-3zvtA: 21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	7 / 12	SER A 298 ASN A 300 LEU A 349 THR A 393 THR A 411 GLY A 412 THR A 413	B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 ( 4.9A) B07 A 500 ( 4.8A) B07 A 500 (-4.8A) B07 A 500 (-3.2A) None	0.91A	4euzA-3zvtA: 20.0	4euzA-3zvtA: 21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_A_CEDA301_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	7 / 12	ALA A 48 SER A 49 SER A 298 ASN A 300 LYS A 410 THR A 411 GLY A 412	B07 A 500 (-3.8A) B07 A 500 (-1.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 (-1.6A) B07 A 500 (-4.8A) B07 A 500 (-3.2A)	0.54A	4n9kA-3zvtA: 20.6	4n9kA-3zvtA: 22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_B_CEDB301_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	7 / 12	ALA A 48 SER A 49 SER A 298 ASN A 300 LYS A 410 THR A 411 GLY A 412	B07 A 500 (-3.8A) B07 A 500 (-1.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 (-1.6A) B07 A 500 (-4.8A) B07 A 500 (-3.2A)	0.56A	4n9kB-3zvtA: 20.5	4n9kB-3zvtA: 22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P7N_A_GCSA702_1 (POLY-BETA-1,6-N-ACET YL-D-GLUCOSAMINE N-DEACETYLASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	3 / 3	ASP A 142 TYR A 147 TRP A 139	None B07 A 500 (-4.1A) None	1.04A	4p7nA-3zvtA: undetectable	4p7nA-3zvtA: 20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM5_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	5 / 12	ASN A 300 THR A 393 LYS A 410 THR A 411 GLY A 412	B07 A 500 ( 4.2A) B07 A 500 ( 4.8A) B07 A 500 (-1.6A) B07 A 500 (-4.8A) B07 A 500 (-3.2A)	0.26A	4pm5A-3zvtA: 20.9	4pm5A-3zvtA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM7_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	5 / 12	LYS A 52 ASN A 300 THR A 393 LYS A 410 GLY A 412	B07 A 500 (-3.4A) B07 A 500 ( 4.2A) B07 A 500 ( 4.8A) B07 A 500 (-1.6A) B07 A 500 (-3.2A)	0.39A	4pm7A-3zvtA: 21.0	4pm7A-3zvtA: 22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM7_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	5 / 12	LYS A 52 SER A 298 ASN A 300 LYS A 410 GLY A 412	B07 A 500 (-3.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 (-1.6A) B07 A 500 (-3.2A)	0.73A	4pm7A-3zvtA: 21.0	4pm7A-3zvtA: 22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM9_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	5 / 12	ASN A 300 THR A 393 LYS A 410 THR A 411 GLY A 412	B07 A 500 ( 4.2A) B07 A 500 ( 4.8A) B07 A 500 (-1.6A) B07 A 500 (-4.8A) B07 A 500 (-3.2A)	0.29A	4pm9A-3zvtA: 20.9	4pm9A-3zvtA: 22.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	5 / 12	ASN A 50 SER A 49 PRO A 445 ILE A 435 SER A 421	None B07 A 500 (-1.4A) None None None	1.15A	4uroA-3zvtA: undetectable	4uroA-3zvtA: 19.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_A_CEDA301_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	6 / 12	ALA A 48 SER A 49 SER A 298 ASN A 300 LYS A 410 GLY A 412	B07 A 500 (-3.8A) B07 A 500 (-1.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 (-1.6A) B07 A 500 (-3.2A)	0.59A	5ghyA-3zvtA: 20.3	5ghyA-3zvtA: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_B_CEDB301_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	6 / 12	ALA A 48 SER A 49 SER A 298 ASN A 300 LYS A 410 GLY A 412	B07 A 500 (-3.8A) B07 A 500 (-1.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 (-1.6A) B07 A 500 (-3.2A)	0.56A	5ghyB-3zvtA: 20.4	5ghyB-3zvtA: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_A_CEDA301_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	7 / 11	ALA A 48 SER A 49 SER A 298 ASN A 300 LYS A 410 THR A 411 GLY A 412	B07 A 500 (-3.8A) B07 A 500 (-1.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 (-1.6A) B07 A 500 (-4.8A) B07 A 500 (-3.2A)	0.55A	5ghzA-3zvtA: 20.4	5ghzA-3zvtA: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_B_CEDB301_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	7 / 10	ALA A 48 SER A 49 SER A 298 ASN A 300 LYS A 410 THR A 411 GLY A 412	B07 A 500 (-3.8A) B07 A 500 (-1.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 (-1.6A) B07 A 500 (-4.8A) B07 A 500 (-3.2A)	0.53A	5ghzB-3zvtA: 20.5	5ghzB-3zvtA: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OY0_2_PQN2843_1 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A2)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	5 / 12	ILE A 12 SER A 49 ALA A 409 LEU A 420 ALA A 419	None B07 A 500 (-1.4A) None None None	1.19A	5oy02-3zvtA: undetectable	5oy02-3zvtA: 10.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	5 / 12	SER A 49 SER A 298 THR A 393 LYS A 410 GLY A 412	B07 A 500 (-1.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.8A) B07 A 500 (-1.6A) B07 A 500 (-3.2A)	0.63A	6b68D-3zvtA: 20.2	6b68D-3zvtA: 10.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	6 / 12	SER A 49 SER A 298 THR A 393 THR A 411 GLY A 412 THR A 413	B07 A 500 (-1.4A) B07 A 500 (-1.4A) B07 A 500 ( 4.8A) B07 A 500 (-4.8A) B07 A 500 (-3.2A) None	0.88A	6b69D-3zvtA: 20.2	6b69D-3zvtA: 10.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	6 / 12	SER A 298 THR A 393 LYS A 410 THR A 411 GLY A 412 THR A 413	B07 A 500 (-1.4A) B07 A 500 ( 4.8A) B07 A 500 (-1.6A) B07 A 500 (-4.8A) B07 A 500 (-3.2A) None	0.68A	6b69D-3zvtA: 20.2	6b69D-3zvtA: 10.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	6 / 12	SER A 298 THR A 393 LYS A 410 THR A 411 GLY A 412 THR A 413	B07 A 500 (-1.4A) B07 A 500 ( 4.8A) B07 A 500 (-1.6A) B07 A 500 (-4.8A) B07 A 500 (-3.2A) None	0.80A	6b6dA-3zvtA: 20.0	6b6dA-3zvtA: 10.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C79_A_CE3A301_1 (BETA-LACTAMASE TOHO-1)	3zvt	D-ALANYL-D-ALANINE CARBOXYPEPTIDASE (Actinomadura sp. R39)	5 / 12	SER A 298 ASN A 300 THR A 393 LYS A 410 GLY A 412	B07 A 500 (-1.4A) B07 A 500 ( 4.2A) B07 A 500 ( 4.8A) B07 A 500 (-1.6A) B07 A 500 (-3.2A)	0.34A	6c79A-3zvtA: 20.8	6c79A-3zvtA: 11.53

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1GHM_A_CEDA1_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",8,"ALA A  48;SER A  49;LYS A  52;TYR A 147;SER A 298;ASN A 300;LYS A 410;GLY A 412","B07 A 500 (-3.8A);B07 A 500 (-1.4A);B07 A 500 (-3.4A);B07 A 500 (-4.1A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 (-1.6A);B07 A 500 (-3.2A)","1.00A","1ghmA-3zvtA:7.1",null],["1HK3_A_T44A3003_1","SERUM ALBUMIN","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",3,"LYS A  52;ALA A  56;MET A 295","B07 A 500 (-3.4A);None;None","0.98A","1hk3A-3zvtA:undetectable","1ghmA-3zvtA:20.94"],["1I2W_A_CFXA1300_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",8,"ALA A  48;SER A  49;LYS A  52;SER A 298;ASN A 300;THR A 393;LYS A 410;GLY A 412","B07 A 500 (-3.8A);B07 A 500 (-1.4A);B07 A 500 (-3.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 ( 4.8A);B07 A 500 (-1.6A);B07 A 500 (-3.2A)","0.65A","1i2wA-3zvtA:20.3","1hk3A-3zvtA:23.67"],["1I2W_B_CFXB2300_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",7,"ALA A  48;SER A  49;LYS A  52;SER A 298;ASN A 300;THR A 393;GLY A 412","B07 A 500 (-3.8A);B07 A 500 (-1.4A);B07 A 500 (-3.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 ( 4.8A);B07 A 500 (-3.2A)","0.67A","1i2wB-3zvtA:20.5","1i2wA-3zvtA:21.41"],["1YMX_A_CFXA1001_1","BETA-LACTAMASE CTX-M-9","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",7,"SER A  49;LYS A  52;SER A 298;ASN A 300;THR A 393;LYS A 410;GLY A 412","B07 A 500 (-1.4A);B07 A 500 (-3.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 ( 4.8A);B07 A 500 (-1.6A);B07 A 500 (-3.2A)","0.62A","1ymxA-3zvtA:20.8","1i2wB-3zvtA:21.41"],["1YMX_B_CFXB1002_1","BETA-LACTAMASE CTX-M-9","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",6,"SER A  49;LYS A  52;SER A 298;ASN A 300;LYS A 410;GLY A 412","B07 A 500 (-1.4A);B07 A 500 (-3.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 (-1.6A);B07 A 500 (-3.2A)","0.58A","1ymxB-3zvtA:21.0","1ymxA-3zvtA:23.16"],["3HLW_A_CE3A301_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",6,"LYS A  52;SER A 298;ASN A 300;THR A 393;LYS A 410;GLY A 412","B07 A 500 (-3.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 ( 4.8A);B07 A 500 (-1.6A);B07 A 500 (-3.2A)","0.41A","3hlwA-3zvtA:20.9","1ymxB-3zvtA:23.16"],["3HLW_B_CE3B302_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",6,"SER A 298;ASN A 300;THR A 393;LYS A 410;THR A 411;GLY A 412","B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 ( 4.8A);B07 A 500 (-1.6A);B07 A 500 (-4.8A);B07 A 500 (-3.2A)","0.33A","3hlwB-3zvtA:21.1","3hlwA-3zvtA:22.94"],["3HUO_A_PNNA300_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",5,"LYS A  52;ASN A 300;LYS A 410;THR A 411;GLY A 412","B07 A 500 (-3.4A);B07 A 500 ( 4.2A);B07 A 500 (-1.6A);B07 A 500 (-4.8A);B07 A 500 (-3.2A)","0.34A","3huoA-3zvtA:20.9","3hlwB-3zvtA:22.94"],["3KP2_A_PNNA5001_0","TRANSCRIPTIONAL REGULATOR TCAR","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",4,"LEU A 446;GLN A 449;SER A 418;ASN A 300","None;None;None;B07 A 500 ( 4.2A)","1.13A","3kp2A-3zvtA:undetectable;3kp2B-3zvtA:undetectable","3huoA-3zvtA:22.94"],["3MZE_A_CFXA364_1","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",6,"ALA A  48;LYS A  52;ASN A 300;LEU A 349;THR A 411;GLY A 412","B07 A 500 (-3.8A);B07 A 500 (-3.4A);B07 A 500 ( 4.2A);B07 A 500 ( 4.9A);B07 A 500 (-4.8A);B07 A 500 (-3.2A)","0.62A","3mzeA-3zvtA:19.4","3kp2A-3zvtA:16.15;3kp2B-3zvtA:16.15"],["3MZE_A_CFXA364_1","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",6,"ALA A  48;SER A  49;LYS A  52;ASN A 300;THR A 411;GLY A 412","B07 A 500 (-3.8A);B07 A 500 (-1.4A);B07 A 500 (-3.4A);B07 A 500 ( 4.2A);B07 A 500 (-4.8A);B07 A 500 (-3.2A)","0.71A","3mzeA-3zvtA:19.4","3mzeA-3zvtA:24.48"],["3P5N_A_RBFA190_1","RIBOFLAVIN UPTAKE PROTEIN","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",5,"ASP A 345;GLY A 348;ALA A  48;ALA A 419;ASN A 438","None;B07 A 500 (-4.7A);B07 A 500 (-3.8A);None;None","1.10A","3p5nA-3zvtA:undetectable","3mzeA-3zvtA:24.48"],["3P5N_B_RBFB190_1","RIBOFLAVIN UPTAKE PROTEIN","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",5,"ASP A 345;GLY A 348;ALA A  48;ALA A 419;ASN A 438","None;B07 A 500 (-4.7A);B07 A 500 (-3.8A);None;None","1.10A","3p5nB-3zvtA:undetectable","3p5nA-3zvtA:16.99"],["3Q07_A_WPPA300_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",5,"LYS A  52;SER A 298;ASN A 300;LYS A 410;GLY A 412","B07 A 500 (-3.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 (-1.6A);B07 A 500 (-3.2A)","0.38A","3q07A-3zvtA:20.7","3p5nB-3zvtA:16.99"],["3Q07_B_WPPB400_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",5,"LYS A  52;SER A 298;ASN A 300;LYS A 410;GLY A 412","B07 A 500 (-3.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 (-1.6A);B07 A 500 (-3.2A)","0.38A","3q07B-3zvtA:20.9","3q07A-3zvtA:22.94"],["3SH8_A_CEDA1_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",7,"ALA A  48;SER A  49;SER A 298;ASN A 300;LYS A 410;THR A 411;GLY A 412","B07 A 500 (-3.8A);B07 A 500 (-1.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 (-1.6A);B07 A 500 (-4.8A);B07 A 500 (-3.2A)","0.53A","3sh8A-3zvtA:20.4","3q07B-3zvtA:22.94"],["3SH8_B_CEDB1_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",7,"ALA A  48;SER A  49;LYS A  52;SER A 298;ASN A 300;LYS A 410;GLY A 412","B07 A 500 (-3.8A);B07 A 500 (-1.4A);B07 A 500 (-3.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 (-1.6A);B07 A 500 (-3.2A)","0.60A","3sh8B-3zvtA:20.3","3sh8A-3zvtA:22.22"],["4EUZ_A_MEMA401_1","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",8,"LYS A  52;SER A 298;ASN A 300;THR A 393;LYS A 410;THR A 411;GLY A 412;THR A 413","B07 A 500 (-3.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 ( 4.8A);B07 A 500 (-1.6A);B07 A 500 (-4.8A);B07 A 500 (-3.2A);None","0.76A","4euzA-3zvtA:20.0","3sh8B-3zvtA:22.22"],["4EUZ_A_MEMA401_1","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",7,"SER A 298;ASN A 300;LEU A 349;THR A 393;THR A 411;GLY A 412;THR A 413","B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 ( 4.9A);B07 A 500 ( 4.8A);B07 A 500 (-4.8A);B07 A 500 (-3.2A);None","0.91A","4euzA-3zvtA:20.0","4euzA-3zvtA:21.84"],["4N9K_A_CEDA301_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",7,"ALA A  48;SER A  49;SER A 298;ASN A 300;LYS A 410;THR A 411;GLY A 412","B07 A 500 (-3.8A);B07 A 500 (-1.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 (-1.6A);B07 A 500 (-4.8A);B07 A 500 (-3.2A)","0.54A","4n9kA-3zvtA:20.6","4euzA-3zvtA:21.84"],["4N9K_B_CEDB301_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",7,"ALA A  48;SER A  49;SER A 298;ASN A 300;LYS A 410;THR A 411;GLY A 412","B07 A 500 (-3.8A);B07 A 500 (-1.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 (-1.6A);B07 A 500 (-4.8A);B07 A 500 (-3.2A)","0.56A","4n9kB-3zvtA:20.5","4n9kA-3zvtA:22.12"],["4P7N_A_GCSA702_1","POLY-BETA-1,6-N-ACETYL-D-GLUCOSAMINE N-DEACETYLASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",3,"ASP A 142;TYR A 147;TRP A 139","None;B07 A 500 (-4.1A);None","1.04A","4p7nA-3zvtA:undetectable","4n9kB-3zvtA:22.12"],["4PM5_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",5,"ASN A 300;THR A 393;LYS A 410;THR A 411;GLY A 412","B07 A 500 ( 4.2A);B07 A 500 ( 4.8A);B07 A 500 (-1.6A);B07 A 500 (-4.8A);B07 A 500 (-3.2A)","0.26A","4pm5A-3zvtA:20.9","4p7nA-3zvtA:20.26"],["4PM7_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",5,"LYS A  52;ASN A 300;THR A 393;LYS A 410;GLY A 412","B07 A 500 (-3.4A);B07 A 500 ( 4.2A);B07 A 500 ( 4.8A);B07 A 500 (-1.6A);B07 A 500 (-3.2A)","0.39A","4pm7A-3zvtA:21.0","4pm5A-3zvtA:22.48"],["4PM7_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",5,"LYS A  52;SER A 298;ASN A 300;LYS A 410;GLY A 412","B07 A 500 (-3.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 (-1.6A);B07 A 500 (-3.2A)","0.73A","4pm7A-3zvtA:21.0","4pm7A-3zvtA:22.51"],["4PM9_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",5,"ASN A 300;THR A 393;LYS A 410;THR A 411;GLY A 412","B07 A 500 ( 4.2A);B07 A 500 ( 4.8A);B07 A 500 (-1.6A);B07 A 500 (-4.8A);B07 A 500 (-3.2A)","0.29A","4pm9A-3zvtA:20.9","4pm7A-3zvtA:22.51"],["4URO_A_NOVA2000_1","DNA GYRASE SUBUNIT B","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",5,"ASN A  50;SER A  49;PRO A 445;ILE A 435;SER A 421","None;B07 A 500 (-1.4A);None;None;None","1.15A","4uroA-3zvtA:undetectable","4pm9A-3zvtA:22.61"],["5GHY_A_CEDA301_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",6,"ALA A  48;SER A  49;SER A 298;ASN A 300;LYS A 410;GLY A 412","B07 A 500 (-3.8A);B07 A 500 (-1.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 (-1.6A);B07 A 500 (-3.2A)","0.59A","5ghyA-3zvtA:20.3","4uroA-3zvtA:19.70"],["5GHY_B_CEDB301_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",6,"ALA A  48;SER A  49;SER A 298;ASN A 300;LYS A 410;GLY A 412","B07 A 500 (-3.8A);B07 A 500 (-1.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 (-1.6A);B07 A 500 (-3.2A)","0.56A","5ghyB-3zvtA:20.4","5ghyA-3zvtA:22.35"],["5GHZ_A_CEDA301_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",7,"ALA A  48;SER A  49;SER A 298;ASN A 300;LYS A 410;THR A 411;GLY A 412","B07 A 500 (-3.8A);B07 A 500 (-1.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 (-1.6A);B07 A 500 (-4.8A);B07 A 500 (-3.2A)","0.55A","5ghzA-3zvtA:20.4","5ghyB-3zvtA:22.35"],["5GHZ_B_CEDB301_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",7,"ALA A  48;SER A  49;SER A 298;ASN A 300;LYS A 410;THR A 411;GLY A 412","B07 A 500 (-3.8A);B07 A 500 (-1.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 (-1.6A);B07 A 500 (-4.8A);B07 A 500 (-3.2A)","0.53A","5ghzB-3zvtA:20.5","5ghzA-3zvtA:22.35"],["5OY0_2_PQN2843_1","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A2","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",5,"ILE A  12;SER A  49;ALA A 409;LEU A 420;ALA A 419","None;B07 A 500 (-1.4A);None;None;None","1.19A","5oy02-3zvtA:undetectable","5ghzB-3zvtA:22.35"],["6B68_D_9F2D400_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",5,"SER A  49;SER A 298;THR A 393;LYS A 410;GLY A 412","B07 A 500 (-1.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.8A);B07 A 500 (-1.6A);B07 A 500 (-3.2A)","0.63A","6b68D-3zvtA:20.2","5oy02-3zvtA:10.14"],["6B69_D_9F2D301_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",6,"SER A  49;SER A 298;THR A 393;THR A 411;GLY A 412;THR A 413","B07 A 500 (-1.4A);B07 A 500 (-1.4A);B07 A 500 ( 4.8A);B07 A 500 (-4.8A);B07 A 500 (-3.2A);None","0.88A","6b69D-3zvtA:20.2","6b68D-3zvtA:10.47"],["6B69_D_9F2D301_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",6,"SER A 298;THR A 393;LYS A 410;THR A 411;GLY A 412;THR A 413","B07 A 500 (-1.4A);B07 A 500 ( 4.8A);B07 A 500 (-1.6A);B07 A 500 (-4.8A);B07 A 500 (-3.2A);None","0.68A","6b69D-3zvtA:20.2","6b69D-3zvtA:10.47"],["6B6D_A_9F2A302_1","BETA-LACTAMASE","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",6,"SER A 298;THR A 393;LYS A 410;THR A 411;GLY A 412;THR A 413","B07 A 500 (-1.4A);B07 A 500 ( 4.8A);B07 A 500 (-1.6A);B07 A 500 (-4.8A);B07 A 500 (-3.2A);None","0.80A","6b6dA-3zvtA:20.0","6b69D-3zvtA:10.47"],["6C79_A_CE3A301_1","BETA-LACTAMASE TOHO-1","3zvt","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE","Actinomadura sp. R39",5,"SER A 298;ASN A 300;THR A 393;LYS A 410;GLY A 412","B07 A 500 (-1.4A);B07 A 500 ( 4.2A);B07 A 500 ( 4.8A);B07 A 500 (-1.6A);B07 A 500 (-3.2A)","0.34A","6c79A-3zvtA:20.8","6b6dA-3zvtA:10.47"]]